Qualigen Therapeutics (NASDAQ QLGN)
Qualigen Therapeutics (NASDAQ QLGN) is a biotechnology company focused on the development and commercialization of novel therapeutic products for cancer therapy and infectious disease treatments using nanoparticle coating technology. Our automated analysis reveals this stock has passed 11/33 due diligence checks and its fundamentals are generally average. Furthermore, its dividend payout history is relatively consistent, […]